Article
Chromatin accessibility profiles of castration-resistant prostate cancers reveal novel subtypes and therapeutic vulnerabilities
2020-10-26
Abstract excerpt
In castration-resistant prostate cancer (CRPC), the loss of androgen receptor (AR)-dependence due to lineage plasticity, which has become more prevalent, leads to clinically highly aggressive tumors with few therapeutic options and is mechanistically poorly defined. To identify the master transcription factors (TFs) of CRPC in a subtype-specific manner, we derived and collected 29 metastatic human prostate cancer...
Topics
Open a Topic to create a Post that cites this publication.
- Cancer, Lipids, and Metabolism
- Cancer-related gene regulation
- Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
- Hippo pathway signaling and YAP/TAZ
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
- Protein Degradation and Inhibitors
- Ubiquitin and proteasome pathways
Identifiers and source
- Literature Corpus work
- ffc6c30e-8ec7-5ee2-93a0-d44e02746df7
- DOI
- 10.1101/2020.10.26.355925
